PDCD1 and neoplasm: However, we observed a trend toward increased PD-L1 expression in tumor cells (CD45−) and tumor-associated leukocytes (CD45+) consistent with activation of IFNγ signaling in anti-PD-1-treated animals (Supplementary Fig. 3c, d).